MA49703A - Nouveaux intermédiaires utiles pour la synthèse de dérivés d'aminopyrimidine, leur procédé de préparation et procédé de préparation de dérivés d'aminopyrimidine à l'aide de ceux-ci - Google Patents
Nouveaux intermédiaires utiles pour la synthèse de dérivés d'aminopyrimidine, leur procédé de préparation et procédé de préparation de dérivés d'aminopyrimidine à l'aide de ceux-ciInfo
- Publication number
- MA49703A MA49703A MA049703A MA49703A MA49703A MA 49703 A MA49703 A MA 49703A MA 049703 A MA049703 A MA 049703A MA 49703 A MA49703 A MA 49703A MA 49703 A MA49703 A MA 49703A
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- aminopyrimidine derivatives
- synthesis
- new useful
- aminopyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20170096220 | 2017-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA49703A true MA49703A (fr) | 2021-04-21 |
Family
ID=65040817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA049703A MA49703A (fr) | 2017-07-28 | 2018-07-25 | Nouveaux intermédiaires utiles pour la synthèse de dérivés d'aminopyrimidine, leur procédé de préparation et procédé de préparation de dérivés d'aminopyrimidine à l'aide de ceux-ci |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US10858353B2 (fr) |
| EP (1) | EP3658553B1 (fr) |
| JP (1) | JP7216704B2 (fr) |
| KR (1) | KR20190013554A (fr) |
| CN (1) | CN111032650A (fr) |
| AU (1) | AU2018308039B2 (fr) |
| BR (1) | BR112020001396A2 (fr) |
| CA (1) | CA3069408A1 (fr) |
| CO (1) | CO2020000595A2 (fr) |
| DK (1) | DK3658553T3 (fr) |
| EA (1) | EA038856B1 (fr) |
| ES (1) | ES2923278T3 (fr) |
| HR (1) | HRP20220848T1 (fr) |
| HU (1) | HUE059501T2 (fr) |
| IL (1) | IL271974B (fr) |
| LT (1) | LT3658553T (fr) |
| MA (1) | MA49703A (fr) |
| PH (1) | PH12020500070A1 (fr) |
| PL (1) | PL3658553T3 (fr) |
| PT (1) | PT3658553T (fr) |
| RS (1) | RS63497B1 (fr) |
| SA (1) | SA520411120B1 (fr) |
| SG (1) | SG11201913520YA (fr) |
| SI (1) | SI3658553T1 (fr) |
| UA (1) | UA125664C2 (fr) |
| WO (1) | WO2019022486A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020230091A1 (fr) | 2019-05-14 | 2020-11-19 | Janssen Biotech, Inc. | Polythérapies avec des anticorps anti-egfr/c-met bispécifiques et des inhibiteurs de tyrosine kinase egfr de troisième génération |
| US11850248B2 (en) | 2019-05-14 | 2023-12-26 | Yuhan Corporation | Therapies with 3rd generation EGFR tyrosine kinase inhibitors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102811619B (zh) * | 2009-11-13 | 2015-04-22 | 金纳斯克公司 | 激酶抑制剂 |
| CN105461695B (zh) * | 2014-09-29 | 2018-03-27 | 齐鲁制药有限公司 | 嘧啶或三嗪衍生物及其制备方法和用途 |
| SG11201701960XA (en) * | 2014-10-13 | 2017-04-27 | Yuhan Corp | Compounds and compositions for modulating egfr mutant kinase activities |
| CN104788427B (zh) * | 2015-02-05 | 2017-05-31 | 上海泓博智源医药股份有限公司 | 3‑(2‑嘧啶氨基)苯基丙烯酰胺类化合物及其应用 |
| CN107614503B (zh) | 2015-04-29 | 2020-03-10 | 广东众生药业股份有限公司 | 稠环或三环芳基嘧啶化合物用作激酶抑制剂 |
| WO2017027768A1 (fr) * | 2015-08-13 | 2017-02-16 | The Broad Institute, Inc. | Compositions et procédés pour traiter la tuberculose |
| PL3658547T3 (pl) | 2017-07-28 | 2024-01-03 | Yuhan Corporation | Sposób wytwarzania n-(5-(4-(4-formylo-3-fenylo-1h-pirazol-1-ilo)pirymidyn-2-yloamino)-4-metoksy-2-morfolinofenylo)akrylamidu |
-
2018
- 2018-07-25 LT LTEPPCT/KR2018/008381T patent/LT3658553T/lt unknown
- 2018-07-25 PL PL18838173.5T patent/PL3658553T3/pl unknown
- 2018-07-25 EA EA202090385A patent/EA038856B1/ru unknown
- 2018-07-25 US US16/633,695 patent/US10858353B2/en active Active
- 2018-07-25 CA CA3069408A patent/CA3069408A1/fr active Pending
- 2018-07-25 MA MA049703A patent/MA49703A/fr unknown
- 2018-07-25 JP JP2020503944A patent/JP7216704B2/ja active Active
- 2018-07-25 EP EP18838173.5A patent/EP3658553B1/fr active Active
- 2018-07-25 HR HRP20220848TT patent/HRP20220848T1/hr unknown
- 2018-07-25 RS RS20220706A patent/RS63497B1/sr unknown
- 2018-07-25 HU HUE18838173A patent/HUE059501T2/hu unknown
- 2018-07-25 CN CN201880049025.7A patent/CN111032650A/zh active Pending
- 2018-07-25 DK DK18838173.5T patent/DK3658553T3/da active
- 2018-07-25 WO PCT/KR2018/008381 patent/WO2019022486A1/fr active Application Filing
- 2018-07-25 PT PT188381735T patent/PT3658553T/pt unknown
- 2018-07-25 IL IL271974A patent/IL271974B/en unknown
- 2018-07-25 UA UAA202001305A patent/UA125664C2/uk unknown
- 2018-07-25 ES ES18838173T patent/ES2923278T3/es active Active
- 2018-07-25 AU AU2018308039A patent/AU2018308039B2/en active Active
- 2018-07-25 BR BR112020001396-0A patent/BR112020001396A2/pt unknown
- 2018-07-25 SG SG11201913520YA patent/SG11201913520YA/en unknown
- 2018-07-25 KR KR1020180086377A patent/KR20190013554A/ko active IP Right Grant
- 2018-07-25 SI SI201830722T patent/SI3658553T1/sl unknown
-
2020
- 2020-01-09 PH PH12020500070A patent/PH12020500070A1/en unknown
- 2020-01-20 CO CONC2020/0000595A patent/CO2020000595A2/es unknown
- 2020-01-22 SA SA520411120A patent/SA520411120B1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3658553B1 (fr) | 2022-06-15 |
| PL3658553T3 (pl) | 2022-10-10 |
| PT3658553T (pt) | 2022-09-23 |
| AU2018308039A1 (en) | 2020-01-30 |
| CA3069408A1 (fr) | 2019-01-31 |
| HRP20220848T1 (hr) | 2022-10-14 |
| US20200207750A1 (en) | 2020-07-02 |
| CO2020000595A2 (es) | 2020-05-05 |
| EA038856B1 (ru) | 2021-10-28 |
| BR112020001396A2 (pt) | 2020-08-11 |
| EP3658553A1 (fr) | 2020-06-03 |
| IL271974B (en) | 2022-08-01 |
| RS63497B1 (sr) | 2022-09-30 |
| AU2018308039B2 (en) | 2022-04-14 |
| SA520411120B1 (ar) | 2022-08-25 |
| SI3658553T1 (sl) | 2022-10-28 |
| ES2923278T3 (es) | 2022-09-26 |
| JP2020528437A (ja) | 2020-09-24 |
| EA202090385A1 (ru) | 2020-09-09 |
| EP3658553A4 (fr) | 2021-04-21 |
| KR20190013554A (ko) | 2019-02-11 |
| DK3658553T3 (da) | 2022-07-25 |
| JP7216704B2 (ja) | 2023-02-01 |
| IL271974A (en) | 2020-02-27 |
| US10858353B2 (en) | 2020-12-08 |
| WO2019022486A1 (fr) | 2019-01-31 |
| UA125664C2 (uk) | 2022-05-11 |
| CN111032650A (zh) | 2020-04-17 |
| PH12020500070A1 (en) | 2020-12-07 |
| SG11201913520YA (en) | 2020-02-27 |
| HUE059501T2 (hu) | 2022-11-28 |
| LT3658553T (lt) | 2022-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA46479A (fr) | Procédés et intermédiaires pour la préparation de nouveaux composés substitués de 6,7-dihydro-5h-benzo[7]annulène | |
| MA46240A (fr) | Compositions d'arn de haute pureté et procédés pour leur préparation | |
| FR3037957B1 (fr) | Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| MA52665A (fr) | Procédé d'amélioration de l'expression de l'hémoglobine foetale | |
| MA51988A (fr) | Procédé pour la préparation de composés utiles à traiter l'amyotrophie spinale | |
| MA49700A (fr) | Procédé amélioré pour la préparation de dérivés d'aminopyrimidine | |
| MA44127A (fr) | Procédés de synthèse pour la préparation de di(4-méthylbenzènesulfonate) de 2-amino-3-méthylbutanoate de (s)-(2r,3r,11br)-3-isobutyl-9,10-diméthoxy-2,3,4,6,7,11b-hexahydro-1h-pyrido[2,1,-a]isoquinoléin-2-yl | |
| MA43835A (fr) | Procédé de préparation de lieurs de médicaments pégylés et leurs intermédiaires | |
| MA37206B1 (fr) | Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| MA53370A (fr) | Procédé et intermédiaires pour la préparation de bilastine | |
| MA52631A (fr) | Compositions et méthodes pour le traitement de la maladie de parkinson | |
| HUE055701T2 (hu) | Eljárás 3-fenil-2,3,4,8,9,10-hexahidropirano[2,3-f]kromén származékok, azok optikai izomere elõállítására és az eljárás intermedierjei | |
| MA45768A (fr) | Procédé pour la préparation de compositions d'immunoglobulines | |
| MA55917A (fr) | Procédé de cristallisation de dérivés d'aripiprazole dans des formulations à libération prolongée pour le traitement de la schizophrénie | |
| MA49472A (fr) | Procédé de préparation d'intermédiaire de dérivé de 4-méthoxypyrrole | |
| CY1123494T1 (el) | Enωσeiς etepoapyλo-kapboξamiδioy ως anaσtoλeiς thς ripk2 | |
| MA49703A (fr) | Nouveaux intermédiaires utiles pour la synthèse de dérivés d'aminopyrimidine, leur procédé de préparation et procédé de préparation de dérivés d'aminopyrimidine à l'aide de ceux-ci | |
| MA54792A (fr) | Compositions et méthodes pour le traitement de la maladie de parkinson | |
| MA50517A (fr) | Procédé de préparation d'intermédiaire de dérivé de 4-méthoxypyrrole | |
| MA51432A (fr) | Procédé de préparation d'une amino-pyrimidine et de ses intermédiaires | |
| CY1122172T1 (el) | Τροποποιητες θειαζολης των a3 υποδοχεων αδενοσινης | |
| MA51870A (fr) | Procédé pour la préparation de composés coupleurs de médicaments | |
| IL276483B1 (en) | A continuous process for the preparation of trazodone | |
| MA49555A (fr) | Procédé amélioré de préparation d'imetelstat | |
| MA53900A (fr) | Nouveaux dérivés d'amino-pyrimidonyl-pipéridinyl, leur procédé de préparation et compositions pharmaceutiques les contenant |